病例报告:开放主动脉缩窄修复术后胸降主动脉瘤的创新腔内修复技术
本文报告一例48岁男性,既往因主动脉缩窄接受开放手术修复,术后发生胸降主动脉瘤,行TEVAR治疗,并采用血管封堵器成功封闭残余缩窄。摘要指出开放缩窄修复术后动脉瘤发生率为11-24%,未治疗者并发症和死亡风险高;TEVAR因病变邻近弓上血管且缩窄仍存在而具有挑战性。
要点
- 开放主动脉缩窄修复术后动脉瘤发生率为11-24%,需长期随访监测。
- TEVAR可作为此类再手术高危患者的开放手术替代方案。
- 病变邻近弓上血管及残余缩窄使TEVAR操作具有挑战性。
核心结论
- 开放主动脉缩窄修复术后可发生胸降主动脉瘤,TEVAR联合血管封堵器封闭缩窄在该病例中可行。
研究设计与样本
- 个案病例报告:一例48岁男性,既往开放手术治疗主动脉缩窄,因术后胸降主动脉瘤接受TEVAR。
- 摘要提及开放缩窄修复术后动脉瘤发生率为11-24%。
主要发现
- 该48岁男性在既往开放缩窄修复后发生胸降主动脉瘤。
- TEVAR术中采用血管封堵器装置成功封闭主动脉缩窄。
- 作者认为TEVAR在此类情况下是开放再手术的可行且安全的替代方案。
关键数值与推荐
- 开放主动脉缩窄修复术后动脉瘤发生率为11-24%。
- 病变邻近弓上血管且缩窄仍存在,使TEVAR具有挑战性。
临床怎么用
- 对开放缩窄修复术后患者应长期随访,警惕晚期动脉瘤形成。
- 对再手术高危的缩窄术后动脉瘤患者,可考虑TEVAR并评估同期处理残余缩窄。
局限性
- 本文为单例病例报告,结果不能推广至一般人群。
- 摘要未报告随访时长、器械规格及远期结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
It was once postulated that open surgical repair of coarctation of the aorta during childhood patients was cured. However, long-term follow-up has been significant for late problems such as an aneurysm. The incidence of such aneurysm after open surgical coarctation repair is 11-24%. If such an aneurysm is left untreated, patients are at a high risk of morbidity and mortality. Prior to the endovascular era, patients would require a redo open repair which in itself is a highly morbid operation. Currently, thoracic endovascular aortic repair (TEVAR) has been reported as a feasible and safe alternative to open surgical reprocedures in this context. However, TEVAR might be challenging due to the proximity of the pathology to supraaortic vessels and the ongoing presence of the coarctation. We are reporting a unique case of a 48-year-old male undergoing TEVAR due to aortic aneurysm after previous surgical coarctation treatment and successful closure of the coarctation with a vascular plug device.
引用
- Parsa P, Eidt J, Rios A, et al. Case Report: An Innovative Endovascular Technique for Repair of Descending Thoracic Aortic Aneurysm following an Open Coarctation Repair. Ann Vasc Surg. 2017. PMID: 28479463. doi:10.1016/j.avsg.2017.04.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。